X0609 4 2026-06-25 0 0001635088 Roivant Sciences Ltd. ROIV 0001750050 Sukhatme Mayukh true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM 1 1 0 0 President & CIO 0 Common Shares 2026-06-25 4 M 0 500000 3.85 A 19177617 D Common Shares 2026-06-25 4 S 0 500000 34.13 D 18677617 D Common Shares 2026-06-26 4 M 0 500000 3.85 A 19177617 D Common Shares 2026-06-26 4 S 0 500000 34.08 D 18677617 D Stock Option (Right to Buy) 3.85 2026-06-25 4 M 0 500000 0 D 2032-04-19 Common Stock 500000 14724363 D Stock Option (Right to Buy) 3.85 2026-06-26 4 M 0 500000 0 D 2032-04-19 Common Stock 500000 14224363 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Award of stock options to purchase Common Shares that is fully vested. By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme 2026-06-29